Internet leading source for healthcare info: survey

Share this article:

Nearly four out of five (78.1%) Americans turn to the Internet to gather health information, according to a recent survey from online media and technology firm Burst Media.

Last month, Burst Media conducted an online study of 3,759 Web users 18 and older about how they research healthcare information.

The purpose of the survey was to examine how people research medical and health related information, when that information was accessed and what types of information was most highly in demand.

Key findings included:
*Nine out of 10 of women between the ages of 25-34 (90.1%) seek health information online.

*Web sites and condition-specific Web sites/chats/forums are the most popular resources to turn to for healthcare information, 35.1% and 33.8%, respectively.

* Symptoms and treatments are the most sought after information: More than one-half (54.2%) of respondents use the Internet to gather information about specific illnesses' symptoms and 51.0% use the Web to find information about treatments for a specific illness.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...